Transaction in Own Shares

RNS Number : 0775S
Palace Capital PLC
12 July 2022
 

12 July 2022

Palace Capital PLC

("Palace Capital" or the "Company")

Transaction in own shares

The Company announces that it has purchased the following number of its ordinary shares of 10 pence each in the capital of the Company (the "Shares") through Numis Securities Limited. Following the announcement of the share buyback Programme on 4 July 2022, the purchase concludes this Programme.

Date of purchase:  11 July 2022

Number of Shares purchased:  2,300,000 (two million, three hundred thousand) Shares

Highest price paid per Share:  260 pence / Lowest price paid per Share:  260 pence

Average price paid per Share: 260 pence

The Company intends to hold these Shares in Treasury. Including Shares which have been purchased but not yet settled, the Company holds 2,359,587 Shares in Treasury.

Following the above purchase, the total number of Shares in issue is 44,028,928 (excluding Shares held in Treasury). This number represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

For further information please contact:

PALACE CAPITAL PLC

Steven Owen, Interim Executive Chairman / Matthew Simpson Chief Financial Officer
Tel. +44 (0)20 3301 8330

 

Broker

Numis Securities

Heraclis Economides / Oliver Hardy

Tel: +44 (0)20 7260 1000

 

Broker

Arden Partners plc

Corporate Finance: John Llewellyn-Lloyd/ Elliot Mustoe

Corporate Broking: James Reed-Daunter

Tel: +44 (0)207 614 5900

 

Financial PR 

FTI Consulting

Dido Laurimore/ Giles Barrie

Tel: +44 (0)20 3727 1000

palacecapital@fticonsulting.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSSFMFMFEESESW
UK 100